Last reviewed · How we verify

NCT07251738: ALCARE

Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease

Not yet recruiting Last updated 26 November 2025
What this trial tests

trial testing Assessment of occupational balance, role performance, caregiving burden, and quality of life among carers or family members of individuals with Alzheimer's disease (AD). in Alzheimer Disease (AD) in 66 participants. Not yet recruiting.

Timeline
1 December 2025
Primary endpoint
31 May 2026
31 July 2026

Quick facts

Lead sponsorUniversidad Rey Juan Carlos
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment66
Start date1 December 2025
Primary completion31 May 2026
Estimated completion31 July 2026

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Rey Juan Carlos — full company profile →

Who can join

Eligibility, any sex, with Alzheimer Disease (AD) or Occupational Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to explore the lived experience of caregivers and family members of people with Alzheimer's disease (AD), from the beginning of caregiving through the bereavement process following the patient's death. Using a mixed-methods design, qualitative data will be collected through in-depth interviews and combined with quantitative data obtained from standardized scales. The results will aim to determine whether prolonged caregiving significantly affects the caregiver's or family member's personal, emotional, and occupational well-being, as well as whether it leads to a reorganization of activities of daily living (ADL), an increased perception of burden, and/or a decreased quality of life. The study will also examine the presence of positive adaptation experiences.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Understanding the Lived Experience and Bereavement of Caregivers of People with Alzheimer's Disease: A Mixed-Methods Study Protocol.
    Risquez-Salgado N, García-Bravo S, Huertas-Hoyas E, Pérez-Corrales J, et al · · 2026 · PMID 41975901 · DOI 10.3390/healthcare14070899

Verify or expand the search:

Other recruiting trials for Alzheimer Disease (AD)

Currently open trials in the same condition.

Other Universidad Rey Juan Carlos trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07251738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing